Zomedica Corp (AMEX: ZOM) started the day on Thursday, remained unchanged at $0.13, before settling in for the price of $0.13 at the close. Taking a more long-term approach, ZOM posted a 52-week range of $0.12-$0.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 78.21%. Meanwhile, its Annual Earning per share during the time was 27.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -37.14%. This publicly-traded company’s shares outstanding now amounts to $979.95 million, simultaneously with a float of $962.66 million. The organization now has a market capitalization sitting at $128.57 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1280, while the 200-day Moving Average is $0.1397.
Zomedica Corp (ZOM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. Zomedica Corp’s current insider ownership accounts for 1.76%, in contrast to 8.27% institutional ownership. According to the most recent insider trade that took place on Nov 08 ’24, this organization’s COO bought 150,000 shares at the rate of 0.12, making the entire transaction reach 18,450 in total value, affecting insider ownership by 400,000. Preceding that transaction, on Nov 11 ’24, Company’s Director bought 100,000 for 0.12, making the whole transaction’s value amount to 12,100. This particular insider is now the holder of 2,425,000 in total.
Zomedica Corp (ZOM) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
Zomedica Corp’s EPS decrease for this current 12-month fiscal period is -37.14% and is forecasted to reach -0.03 in the upcoming year.
Zomedica Corp (AMEX: ZOM) Trading Performance Indicators
Let’s observe the current performance indicators for Zomedica Corp (ZOM). It’s Quick Ratio in the last reported quarter now stands at 10.15. The Stock has managed to achieve an average true range (ATR) of 0.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.81.
In the same vein, ZOM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.06, a figure that is expected to reach -0.01 in the next quarter, and analysts are predicting that it will be -0.03 at the market close of one year from today.
Technical Analysis of Zomedica Corp (ZOM)
If we take a close look at the recent performances of Zomedica Corp (AMEX: ZOM), its last 5-days Average volume was 5.03 million that shows progress from its year to date volume of 4.81 million. During the previous 9 days, stock’s Stochastic %D was recorded 31.88% While, its Average True Range was 0.0075.
Raw Stochastic average of Zomedica Corp (ZOM) in the period of the previous 100 days is set at 28.01%, which indicates a major fall in contrast to 37.57% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 75.73% that was higher than 44.59% volatility it exhibited in the past 100-days period.
